The CEO of Lyndra Therapeutics describes the company's technology that turns daily pills into weekly ones - and potentially longer

blonca9
Dec 9, 2024
1 min read

Jessica Ballinger describes the science behind this and how an extended release format can improve health outcomes. Plus, the progress Lyndra has made developing a risperidone based product, and other areas this might be used for.

Recent Posts

See All

The CEO of Tennr, which raised a $101M series C earlier this summer, explains how the company's platform uses large language models to make the patient referral process to specialists more efficient

After exiting stealth with $20 million two weeks ago, Orchestra Bio is out to help science entrepreneurs handle the dollars and cents management and long term planning that business requires

IO Biotech CEO Mai-Britt Zocca discusses the phase 3 pivotal trial result of the cancer vaccine Cylembio in first line advanced melanoma - and the company's strategy ahead

The CEO of Lyndra Therapeutics describes the company's technology that turns daily pills into weekly ones - and potentially longer

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight